The Science and Technology Committee will hold the following rescheduled evidence session in its inquiry into ‘Clinical trials’:
Witnesses
Monday 22 April 2013, Committee Room 8, Palace of Westminster
At 5.15pm
- Dr Catherine Elliott, Director, Clinical Research Interests, Medical Research Council
- Sharmila Nebhrajani, Chief Executive, Association of Medical Research Charities
- Professor Peter Johnson, Chief Clinician, Cancer Research UK
- Nicola Perrin, Head of Policy, Wellcome Trust;
At 6.00pm
- Dr Bina Rawal, Director of Research, Medical and Innovation, Association of the British Pharmaceutical Industry
- Dr James Shannon, Chief Medical Officer, GlaxoSmithKline
- William M Burns, Member of the Board of Directors, Roche
- Dr Ben Goldacre, Wellcome Research Fellow in Epidemiology, London School of Hygiene and Tropical Medicine
Further information
Image: iStockphoto